Role of behavioral health in management of pediatric atopic dermatitis.

Related Articles

Role of behavioral health in management of pediatric atopic dermatitis.

Ann Allergy Asthma Immunol. 2018 Jan;120(1):42-48.e8

Authors: Klinnert MD, Booster G, Copeland M, Darr JM, Meltzer LJ, Miller M, Oland A, Perry S, Wise BK, Bender BG

Abstract
OBJECTIVE: To describe the behavioral components and complications in treating pediatric patients with atopic dermatitis (AD) and the critical role of behavioral health professionals in addressing disease impact and behavioral aspects of disease management for these patients and families.
DATA SOURCES: Studies and review articles were selected from medical and psychology databases for relevance to pertinent topics.
RESULTS: AD has significant negative effects in affected individuals and their families on quality of life, behavioral, emotional, and sleep disturbances, and family functioning. Effective treatment strategies for AD are available, but the challenges for children and parents in coping with disease-related concerns and in following through with the multiple aspects of treatment are considerable. A biopsychosocial model, which incorporates the interplay among biological, psychological, and social dimensions of medical care, can be implemented in various treatment settings to achieve an integrated medical and behavioral health care approach. By sharing a family orientation, using a stress and coping model, and taking into account children's developmental capabilities and concerns, medical and behavioral health care providers are equipped to bring an in-depth understanding and different evidence-based therapeutic tools to address emotional, behavioral, and interpersonal challenges imposed by moderate to severe AD in children and families.
CONCLUSION: Behavioral health and medical providers working together to provide integrated care play a critical role in helping children and families cope with the burdens imposed by AD, successfully manage the disease, and achieve optimal quality of life for affected children and their families.

PMID: 29273127 [PubMed - in process]

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2C0WT67
via IFTTT